Re: “Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis” by Horita et al.

ECIL4 antibacterial group, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN

doi:10.1016/j.cmi.2018.01.012

Re: “Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis” by Horita et al.

ECIL4 antibacterial group, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	662-663
Number of pages	2
Journal	Clinical Microbiology and Infection
Volume	24
Issue number	6
DOIs	https://doi.org/10.1016/j.cmi.2018.01.012
Publication status	Published - Jun 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmi.2018.01.012

Cite this

@article{9da11457572d46d8a1830c7cbf65ef59,

title = "Re: “Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis” by Horita et al.",

author = "D. Averbuch and C. Orasch and M. Mikulska and Livermore, {D. M.} and C. Viscoli and Gyssens, {I. C.} and Kern, {W. V.} and G. Klyasova and O. Marchetti and D. Engelhard and M. Akova and T. Calandra and C. Cordonnier and {ECIL4 antibacterial group, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN}",

year = "2018",

month = jun,

doi = "10.1016/j.cmi.2018.01.012",

language = "English",

volume = "24",

pages = "662--663",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier",

number = "6",

}

Re: “Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis” by Horita et al. / ECIL4 antibacterial group, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN.

In: Clinical Microbiology and Infection, Vol. 24, No. 6, 06.2018, p. 662-663.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Re: “Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis” by Horita et al.

AU - Averbuch, D.

AU - Orasch, C.

AU - Mikulska, M.

AU - Livermore, D. M.

AU - Viscoli, C.

AU - Gyssens, I. C.

AU - Kern, W. V.

AU - Klyasova, G.

AU - Marchetti, O.

AU - Engelhard, D.

AU - Akova, M.

AU - Calandra, T.

AU - Cordonnier, C.

AU - ECIL4 antibacterial group, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN

PY - 2018/6

Y1 - 2018/6

UR - http://www.scopus.com/inward/record.url?scp=85042075643&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2018.01.012

DO - 10.1016/j.cmi.2018.01.012

M3 - Letter

C2 - 29410224

AN - SCOPUS:85042075643

VL - 24

SP - 662

EP - 663

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 6

ER -

Re: “Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis” by Horita et al.

UN SDGs

Access to Document

Other files and links

Cite this